Organ Preservation Market to Reach USD 466.23 Million by 2033 at 8.6% CAGR; North America Leads with 45% Share - Key Players: XVIVO Perfusion AB, CryoLife, Inc., BioLife Solutions, Inc., TransMedics Group, OrganOx Limited

DataM Intelligence has released a new research report titled "Organ Preservation Market Size 2026." The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Organ Preservation Market.

Ready to scale in the Organ Preservation Market? Connect with the right partners and unlock new growth opportunities today: - https://www.datamintelligence.com/partner-identification-enquiry/organ-preservation-market?sai-v

The global organ preservation market reached USD 288.21 million in 2025 and is expected to reach USD 466.23 million by 2033, growing at a CAGR of 8.6% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing number of organ transplant procedures and the rising demand for advanced preservation techniques.

Market growth is primarily fueled by the growing prevalence of chronic diseases such as kidney failure, liver cirrhosis, and heart disorders, which are leading to a higher demand for organ transplants. The increasing gap between organ supply and demand is further emphasizing the need for effective preservation solutions. Additionally, advancements in preservation technologies, including hypothermic and normothermic machine perfusion, are significantly improving organ viability and transplant success rates.

Organ preservation solutions and devices play a critical role in maintaining the functionality and integrity of donor organs between procurement and transplantation. These include preservation solutions, transport systems, and perfusion machines widely used in hospitals, transplant centers, and research institutions. Continuous innovations in biopreservation techniques, along with increasing investments in transplant infrastructure and research, are transforming the market landscape. With growing focus on improving transplant outcomes and extending organ viability, the organ preservation market is emerging as a key segment within the global transplant medicine and healthcare technology industry.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/organ-preservation-market?sai-v

Key Developments

✅ February 2026: Globally, increasing number of organ transplant procedures and rising cases of organ failure significantly accelerated demand for advanced organ preservation solutions, supported by growing healthcare investments and transplant infrastructure expansion.

✅ January 2026: Technological advancements in machine perfusion techniques, including hypothermic and normothermic perfusion systems, gained strong traction, improving organ viability, extending preservation time, and enhancing transplant success rates.

✅ December 2025: Leading companies such as TransMedics Group, Inc., XVIVO Perfusion AB, OrganOx Limited, Paragonix Technologies, and Bridge to Life Ltd. expanded their product portfolios, focusing on advanced perfusion devices, preservation solutions, and transport systems.

✅ November 2025: In emerging markets such as India and China, increasing healthcare expenditure, rising awareness of organ donation, and growing incidence of chronic diseases significantly boosted demand for organ preservation technologies.

✅ October 2025: Innovation accelerated with the development of next-generation preservation solutions and automated perfusion systems designed to reduce ischemia-reperfusion injury and improve long-term organ functionality post-transplant.

✅ September 2025: Across North America and Europe, strong government support, favorable reimbursement policies, and well-established organ procurement networks supported widespread adoption of advanced preservation systems.

The market is steadily evolving toward advanced, technology-driven, and efficiency-focused preservation systems, with strong growth driven by rising transplant demand, continuous innovation in perfusion technologies, and increasing global focus on improving organ viability and transplant outcomes.

Key Players
XVIVO Perfusion AB | CryoLife, Inc. | Lifeline Scientific | BioTime, Inc. | Claris Lifesciences Limited | BioLife Solutions, Inc. | Dr. Franz Köhler Chemie GmbH | Bristol-Myers Squibb | Tolerotech, Inc. | 21st Century Medicine

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=organ-preservation-market?sai-v

Market Drivers

Rising demand for organ transplantation due to increasing cases of organ failure caused by chronic diseases such as diabetes, hypertension, obesity, and cardiovascular disorders is significantly driving the organ preservation market.

Growing shortage of donor organs and widening gap between supply and demand is accelerating the need for advanced preservation techniques to maintain organ viability.

Increasing aging population is contributing to higher incidence of organ failure and boosting transplant procedures globally.

Technological advancements in preservation solutions, including cold storage, hypothermic machine perfusion, and normothermic machine perfusion, are improving graft quality and transplant outcomes.

Rising government initiatives and awareness programs promoting organ donation are supporting transplant volumes and infrastructure development.

Expanding healthcare infrastructure and increasing investments in transplant centers are further strengthening market growth.

Growing adoption of machine perfusion systems that reduce ischemic injury and extend preservation time is enhancing clinical efficiency.

Industry Developments

Rapid advancement in machine perfusion technologies enabling continuous oxygenation and functional assessment of organs before transplantation.

Increasing development of organ-specific preservation solutions such as UW solution, Custodiol HTK, and Perfadex to improve organ viability.

Growing integration of real-time monitoring, AI-based viability assessment, and automated preservation systems to improve transplant success rates.

Expansion of normothermic and hypothermic perfusion techniques allowing better utilization of marginal and high-risk donor organs.

Rising R&D investments by key players focusing on improving storage duration and reducing ischemia-reperfusion injury.

Strategic collaborations, acquisitions, and partnerships among biotech and medical device companies to expand preservation technologies globally.

Increasing focus on portable and cost-effective preservation systems to improve organ transport efficiency.

Regional Insights

North America 45% share: "Leads the market due to advanced transplant infrastructure, high organ donation rates, and strong adoption of innovative preservation technologies."

Europe 25% share: "Growth driven by supportive regulatory frameworks, strong organ donation systems, and continuous technological advancements in preservation techniques."

Asia Pacific 20% share: "Fastest-growing region supported by rising chronic disease burden, improving healthcare infrastructure, and increasing awareness of organ donation."

Latin America 5% share: "Emerging growth driven by improving transplant programs and increasing healthcare investments."

Middle East & Africa 5% share: "Steady growth supported by gradual expansion of transplant infrastructure and rising government initiatives in healthcare development."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/organ-preservation-market?sai-v

Key Segments

➥ By Technique
Static Cold Storage (SCS): Represents the dominant segment, driven by its widespread adoption as a standard, cost-effective, and simple method for short-term organ preservation during transplantation procedures.

Hypothermic Perfusion Preservation (HPP): Represents a significant segment, supported by improved graft viability and reduced ischemic damage compared to static storage methods.

Normothermic Machine Perfusion: Represents a rapidly growing segment, fueled by advancements in organ preservation technology that allow continuous oxygenated blood flow, improving organ quality and transplant outcomes.

Others: Include emerging preservation techniques and hybrid methods under clinical research and development.

➥ By Preservation Solution
University of Wisconsin Solution (UW Solution): Represents the dominant segment, driven by its gold-standard status in organ preservation, particularly for abdominal organs like kidneys and liver.

Custodiol HTK: Represents a significant segment, supported by its effectiveness in multi-organ preservation and ease of use in clinical settings.

Perfadex: Represents a notable segment, primarily used for lung preservation and supported by its specialized formulation.

Collins Solution: Represents a mature segment, historically used in organ preservation with limited but continued application.

Citrate Solutions: Represent a growing segment, driven by cost-effectiveness and use in specific preservation protocols.

Others: Include emerging and customized preservation solutions tailored for specific clinical needs.

➥ By Organ Type
Kidneys: Represent the dominant segment, driven by the high volume of kidney transplants globally and strong demand for effective preservation techniques.

Liver: Represents a major segment, supported by increasing prevalence of liver diseases and rising number of transplant procedures.

Lung: Represents a significant segment, fueled by growing cases of respiratory failure and advancements in lung transplantation techniques.

Heart: Represents a critical segment, driven by life-saving transplant procedures and need for high-precision preservation methods.

Other Organs (Pancreas, Intestine): Represent a growing segment, supported by increasing adoption of multi-organ transplant procedures and advancements in surgical techniques.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.